Topic Archives: AC Immune (ACIU)

I got several reader questions this week about a new recommendation from Dave Lashmet at Stansberry — it looks like this was issued as a recommendation for regular Stansberry Investment Advisory subscribers, not one of Lashmet’s more expensive biotech-focused newsletters, and it’s very light on clues… but let’s see if we can give you anything […]

[ed note: Michael Jorrin, who I like call “Doc Gumshoe,” is a longtime medical writer who shares his thoughts with us a couple times a month — his articles are non-financial in nature, his words and opinions are his own, and you can see his bio and his past pieces here. Enjoy!] Indulge me while […]


  • Avatar

    $ACIU: A new biotech IPO stock debuted last Friday, September 23: AC Immune, based in Switzerland, is a clinical-stag...


    Two biotech IPOs this week might be of some interest. I've personally not been participating in the biotech IPO market b...


    Krystyna: I know of AC Immune. My truthful feeling is that its clinical programs are also-rans. Little distinguishes th...

  • Avatar

    Just read that a company called AC Immune has just filed its F-1 paperwork with the U.S. Securities & Exchange Commissio...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info